Related Experiment Video
Updated: Aug 6, 2026
10:07
High-throughput Screening for Small-molecule Modulators of Inward Rectifier Potassium Channels
Published on: January 27, 2013
In silico classification of HERG channel blockers: a knowledge-based strategy
Elodie Dubus1, Ismaïl Ijjaali, François Petitet
1Aureus Pharma, 174 quai de Jemmapes, 75010 Paris, France. elodie.dubus@aureus-pharma.com
Chemmedchem
|August 8, 2006
Summary
Predictive in silico models effectively screen potential hERG channel blockers, reducing cardiac risks. These computational tools accurately identify compounds that may cause sudden cardiac death, improving drug safety.
Area of Science:
- Pharmacology
- Computational Chemistry
- Cardiovascular Safety
Background:
- hERG potassium channel blockage is a significant safety concern, potentially leading to sudden cardiac death.
- In silico models offer a promising approach for early screening of potential hERG blockers in drug discovery.
Purpose of the Study:
- To develop and evaluate predictive in silico models for identifying hERG channel blockers.
- To assess the accuracy of models in classifying compounds based on their hERG channel inhibitory activity.
Main Methods:
- Utilized recursive partitioning method to build predictive models.
- Trained models on diverse datasets comprising 203 molecules tested for hERG channel activity.
- Developed two-class, three-class, and binary classification models.
Main Results:
- A two-class model achieved 81% accuracy.
- A three-class model (high, moderate, weak blockers) reached 90% accuracy.
- A binary model for high and weak blockers achieved 96% accuracy.
Conclusions:
- In silico models, particularly the 96% accurate binary model, are invaluable for assessing cardiotoxic risks associated with hERG blockage.
- Combining computational modeling with knowledge management enhances the evaluation of drug safety.
- These models can significantly aid in the early stages of drug discovery to mitigate potential cardiac side effects.
Related Concept Videos
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:25Adrenergic Antagonists: Chemistry and Classification of β-Receptor Blockers
β-adrenergic antagonists, or β-blockers, modulate the sympathetic nervous system by targeting β-adrenoceptors and inhibiting catecholamine-mediated sympathetic responses. β-blockers differ in their adrenoceptor subtype affinity, lipophilicity, and α-blocking capabilities. The history of β-blocker development began with the prototype, dichloroisoprenaline, which exhibited partial agonist activity. As a result, propranolol was developed as a pure antagonist but nonselective agent, paving the way...
01:18Patch Clamp
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...